INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

ADPTAdaptive Biotechnologies Corp

CIK 0001478320

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 27
Max Insider Score9
Connections9with evidence

ADPT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$244K
8,881 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Owen Katey EinterzDirector · Aug 28, 2026
  • ← Insider ofevidence
    Bobulsky SusanChief Commercial Officer, MRD · Jun 29, 2026
  • ← Insider ofevidence
    Rubinstein JuliePresident and COO · Mar 26, 2026
0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M
—
11.9K sh
Oct 29, 2026
Oct 29, 2026
traded Oct 29, 2026
+0d
SEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 29, 2026Oct 29, 2026
traded Oct 29, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5,780
200 sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$332K
11.7K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$336K
11.9K sh
Oct 29, 2026Oct 29, 2026
traded Oct 29, 2026
+0dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$80K
3,000 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$221K
8,503 sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$187K
7,381 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$89K
3,378 sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$43K
1,700 sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$248K
10.2K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$110K
4,500 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$150K
5,882 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$151K
5,999 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$286K
11.9K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$289K
11.8K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$2,485
100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$304K
11.9K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$280K
11.6K sh
Oct 16, 2026Oct 16, 2026
traded Oct 16, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 16, 2026Oct 16, 2026
traded Oct 16, 2026
+0dSEC FORM 4

Evidence

6
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$173K
6,781 sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

6
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$132K
5,100 sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$7,635
300 sh
Oct 16, 2026Oct 16, 2026
traded Oct 16, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 16, 2026Oct 16, 2026
traded Oct 16, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$314K
11.9K sh
Oct 9, 2026Oct 13, 2026
traded Oct 9, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 9, 2026Oct 13, 2026
traded Oct 9, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

6
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$233K
9,181 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$303K
11.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

6
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$70K
2,700 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 9, 2026Oct 13, 2026
traded Oct 9, 2026
+4dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC FORM 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$314K
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC FORM 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC FORM 4

Evidence

9
BS
Bobulsky SusanChief Commercial Officer, MRD
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$193K
6,444 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Lo FrancisChief People Officer · Dec 29, 2025
  • ← Insider ofevidence
    Benzeno SharonChief Commercial Ofc Imm Med · Dec 8, 2025
  • ← Insider ofevidence
    Robins Harlan SChief Scientific Officer · Dec 5, 2025
  • ← Insider ofevidence
    Piskel KyleChief Financial Officer · Dec 2, 2025
  • ← Insider ofevidence
    Robins Chad MDirector, CEO and Chairman · Dec 1, 2025